#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Phaeochromocytoma Arginase deficiency Growth hormone deficiency Primary adrenal insufficiency B-cell small lymphocytic lymphoma recurrent Non-Hodgkin's lymphoma refractory Pelizaeus-Merzbacher disease Cardiac arrest Angelman's syndrome Short stature homeobox gene mutation Sickle cell anaemia Spinal muscular atrophy Rett syndrome Measles Cholangitis sclerosing More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Basic Information VEXAS syndrome – Basic Information Acute respiratory distress syndrome – Diagnostics Urea cycle disorder – Life with Disease Splenic marginal zone lymphoma – Basic Information Retinoblastoma Antisynthetase syndrome – Treatment Leiomyosarcoma – Trials in Disease Niemann-Pick disease MELAS syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Recombinant Interferon Beta-1B Berubicin Hydrochloride Ab-729 Ibuprofen Lysine LUMC-BOB1-B7-TCR.1 Daunorubicin Citalopram Hydrochloride Hydrocortisone Ph. Eur. Fosinopril Sodium Vibosameran Pilocarpine Nitrate Biotin Zalunfiban Ezetimibe Alprazolam Sqy51 Calcium Polystyrene Sulfonate Tiragolumab Hhalpc Baxdrostat More therapies…

    Learn about Your Condition

    Pharyngeal cancer stage III Dyspepsia Spermatocele Colon cancer Haematological infection Urinary incontinence H1N1 influenza Netherton's syndrome Congenital pseudarthrosis Turner's syndrome Breast cancer female Aortic valve disease Schizophreniform disorder Triple positive breast cancer Ocular lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Stem Cell Transplantation and Immunotherapy with Rituximab, Dinutuximab Beta, and Drug Combination for Patients with High-Risk Relapsed Neuroblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    Investigated Drugs:
    • ALLOGENEIC PERIPHERAL BLOOD-DERIVED HAEMATOPOIETIC STEM CELLS, TCR ALPHA/BETA+ CD19+ DEPLETED
    • ALLOGENEIC PERIPHERAL BLOOD-DERIVED NK CELLS CD3- CD56+
    • Dinutuximab Beta
    Italy

  • Study on the Impact of Cefepime, Piperacillin-Tazobactam, and Ceftobiprole on Gut Health in Patients with Bone and Joint Infections on Implants

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Cefepime
    • Daptomycin
    • Piperacillin
    France

  • Study on the Safety of Edoxaban for Patients with Porto-Sinusoidal Vascular Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Porto-sinusoidal vascular disorder
    Investigated Drugs:
    • Edoxaban
    Austria

  • Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

    Recruiting

    2 1
    Investigated Drugs:
    • Dnth103
    Denmark France Italy The Netherlands Poland Spain

  • Study of Azacitidine, Venetoclax, and Tagraxofusp for Patients with Higher-Risk Chronic Myelomonocytic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic myelomonocytic leukaemia
    Investigated Drugs:
    • TAGRAXOFUSP
    • Venetoclax
    Germany Italy Spain

  • Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mexiletine
    • Mexiletine Hydrochloride
    Belgium France Germany Italy
Previous Page
1 … 255 256 257 258 259 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!